Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that effective December 13, 2022, Adrian Tyndall, M.D., MPH, FACEP has been appointed as an independent member to the company’s board of directors and will serve on the Quality, Compliance, and Portfolio Management Committee.
October 31, 2022
· 4 min read